Greenland Mines (GRML) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $6.96, +7.24% vs the prior close of $6.49.
- Volume 3.07M shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GRML jumps 7.2% to $6.96. Closed at $6.96, +7.24% vs the prior close of $6.49. Day range $5.81–$7.09, opened at $5.99.
GRML daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — GRML jumps 7.2% to $6.96
- Closed at $6.96, +7.24% vs the prior close of $6.49. Day range $5.81–$7.09, opened at $5.99.
- Volume was 3.07M shares, 0.3x its 50-day average of 10.97M — lighter than usual.
- Price is -7.3% vs its 50-day average ($7.51) and -51.4% vs its 200-day average ($14.32).
- 52-week range $2.82–$37.00; today's close sits at 12% of that range, 81.2% below the 52-week high.
Oct 14, 2026 — GRML jumps 17.1% to $6.49 on 2.7x normal volume
- Closed at $6.49, +17.15% vs the prior close of $5.54. Day range $6.35–$7.53, opened at $7.51.
- Volume was 27.86M shares, 2.7x its 50-day average of 10.41M — unusually heavy trading.
- Price is -14.2% vs its 50-day average ($7.56) and -54.8% vs its 200-day average ($14.36).
- 52-week range $2.82–$37.00; today's close sits at 11% of that range, 82.5% below the 52-week high.
Oct 13, 2026 — GRML slides 8.0% to $5.54
- Closed at $5.54, -7.97% vs the prior close of $6.02. Day range $5.41–$5.88, opened at $5.74.
- Volume was 1.74M shares, 0.2x its 50-day average of 10.38M — lighter than usual.
- Price is -27.3% vs its 50-day average ($7.62) and -61.6% vs its 200-day average ($14.42).
- 52-week range $2.82–$37.00; today's close sits at 8% of that range, 85.0% below the 52-week high.
Oct 12, 2026 — GRML jumps 16.4% to $6.02
- Closed at $6.02, +16.44% vs the prior close of $5.17. Day range $5.05–$6.57, opened at $5.05.
- Volume was 11.86M shares, 1.2x its 50-day average of 10.14M.
- Price is -22.0% vs its 50-day average ($7.71) and -58.4% vs its 200-day average ($14.48).
- 52-week range $2.82–$37.00; today's close sits at 9% of that range, 83.7% below the 52-week high.
Oct 9, 2026 — GRML slides 12.1% to $5.17
- Closed at $5.17, -12.07% vs the prior close of $5.88. Day range $4.93–$6.28, opened at $6.24.
- Volume was 3.68M shares, 0.4x its 50-day average of 10.07M — lighter than usual.
- Price is -33.6% vs its 50-day average ($7.79) and -64.4% vs its 200-day average ($14.54).
- 52-week range $2.82–$37.00; today's close sits at 7% of that range, 86.0% below the 52-week high.
Oct 8, 2026 — GRML rises 0.9% to $5.88
- Closed at $5.88, +0.86% vs the prior close of $5.83. Day range $5.57–$6.11, opened at $5.81.
- Volume was 1.84M shares, 0.2x its 50-day average of 10.03M — lighter than usual.
- Price is -25.4% vs its 50-day average ($7.88) and -59.7% vs its 200-day average ($14.61).
- 52-week range $2.82–$37.00; today's close sits at 9% of that range, 84.1% below the 52-week high.
Oct 7, 2026 — GRML slides 8.6% to $5.83, 5 down days in a row
- Closed at $5.83, -8.62% vs the prior close of $6.38. Day range $5.70–$6.32, opened at $6.00.
- Volume was 1.83M shares, 0.2x its 50-day average of 10.00M — lighter than usual.
- Price is -26.7% vs its 50-day average ($7.95) and -60.3% vs its 200-day average ($14.67).
- 52-week range $2.82–$37.00; today's close sits at 9% of that range, 84.2% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — GRML slides 13.1% to $6.38, 4 down days in a row
- Closed at $6.38, -13.08% vs the prior close of $7.34. Day range $6.05–$7.54, opened at $7.49.
- Volume was 4.86M shares, 0.5x its 50-day average of 9.90M — lighter than usual.
- Price is -20.6% vs its 50-day average ($8.03) and -56.7% vs its 200-day average ($14.74).
- 52-week range $2.82–$37.00; today's close sits at 10% of that range, 82.8% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — GRML slides 6.9% to $7.34, 3 down days in a row
- Closed at $7.34, -6.85% vs the prior close of $7.88. Day range $7.00–$8.65, opened at $8.65.
- Volume was 4.74M shares, 0.5x its 50-day average of 9.81M — lighter than usual.
- Price is -9.4% vs its 50-day average ($8.10) and -50.4% vs its 200-day average ($14.79).
- 52-week range $2.82–$37.00; today's close sits at 13% of that range, 80.2% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — GRML slides 13.5% to $7.88
- Closed at $7.88, -13.50% vs the prior close of $9.11. Day range $7.70–$8.91, opened at $8.79.
- Volume was 4.10M shares, 0.4x its 50-day average of 9.73M — lighter than usual.
- Price is -3.2% vs its 50-day average ($8.14) and -47.0% vs its 200-day average ($14.86).
- 52-week range $2.82–$37.00; today's close sits at 15% of that range, 78.7% below the 52-week high.
- SEC filings that day: 8-K.
GRML latest news & SEC filings
Every SEC filing by or about GRML in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- El-Dada Riad Hussein sold 3,500 shares at $9.35 (≈$32.73K) on Oct 1, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Oct 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 28, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 23, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 23, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 3.02 — Sold unregistered shares.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 5.07 — Reported shareholder vote results.
Sep 2, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 27, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 27, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 25, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Leblanc Jeff bought 14,000 shares at $9.72 (≈$136.08K) on Aug 25, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade GRML
- How much it moves: over the last 20 sessions the average daily move was 24.63% (largest 230.5%). That is a volatile stock.
- Liquidity: about 26.69M shares (≈$185.79M) trade per day on average.
- 52-week position: $6.96 vs a range of $2.82–$37.00 (12% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:50 on Aug 24, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 1 sales; latest: Jeff Leblanc bought 14,000 shares on Aug 25, 2026.
- Latest filings: 8-K Oct 2, 2026; 8-K Sep 28, 2026; 8-K Sep 23, 2026.
- Share count: 158.85M shares outstanding (Aug 17, 2026), +158.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
GRML market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 5.99 | 7.09 | 5.81 | 6.96 | 3.07M |
| Oct 14, 2026 | 7.51 | 7.53 | 6.35 | 6.49 | 27.86M |
| Oct 13, 2026 | 5.74 | 5.88 | 5.41 | 5.54 | 1.74M |
| Oct 12, 2026 | 5.05 | 6.57 | 5.05 | 6.02 | 11.86M |
| Oct 9, 2026 | 6.24 | 6.28 | 4.93 | 5.17 | 3.68M |
| Oct 8, 2026 | 5.81 | 6.11 | 5.57 | 5.88 | 1.84M |
| Oct 7, 2026 | 6.00 | 6.32 | 5.70 | 5.83 | 1.83M |
| Oct 6, 2026 | 7.49 | 7.54 | 6.05 | 6.38 | 4.86M |
| Oct 5, 2026 | 8.65 | 8.65 | 7.00 | 7.34 | 4.74M |
| Oct 2, 2026 | 8.79 | 8.91 | 7.70 | 7.88 | 4.10M |
| Oct 1, 2026 | 10.04 | 10.19 | 8.89 | 9.11 | 3.94M |
| Sep 30, 2026 | 10.67 | 11.06 | 10.02 | 10.62 | 3.97M |
| Sep 29, 2026 | 10.50 | 11.60 | 9.60 | 10.38 | 8.07M |
| Sep 28, 2026 | 13.89 | 14.28 | 11.28 | 11.85 | 9.13M |
| Sep 25, 2026 | 16.48 | 17.38 | 14.42 | 14.66 | 22.89M |
| Sep 24, 2026 | 12.75 | 16.00 | 12.13 | 14.89 | 42.18M |
| Sep 23, 2026 | 17.33 | 17.99 | 10.29 | 11.19 | 53.79M |
| Sep 22, 2026 | 13.70 | 18.21 | 12.61 | 14.15 | 101.02M |
| Sep 21, 2026 | 7.33 | 11.68 | 6.63 | 9.42 | 218.34M |
| Sep 18, 2026 | 2.99 | 3.06 | 2.82 | 2.85 | 4.97M |
About Greenland Mines
Greenland Mines (GRML) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in OMAHA, NE. Fiscal year ends December 31. SEC CIK 1907223.
GRML board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Riad Hussein El-Dada | Director | Jun 26, 2026 |
| Shalom Hirschman | Director | Mar 6, 2026 |
| Jon Mcgarity | Director | Jul 20, 2026 |
| Joseph Sinkule | Chief Executive Officer | Mar 6, 2026 |
| Jason David Sawyer | Director | Jul 23, 2026 |
| Samuel M Zentman | Director | Mar 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jeff Leblanc | Chief Financial Officer | Aug 25, 2026 |
| Joseph Sinkule | Chief Executive Officer | Mar 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Jeff Leblanc | Buy | 14,000 | $9.72 |
| Jul 22, 2026 | Jason David Sawyer | Buy | 240,000 | $0.23 |
| Jul 20, 2026 | Jon Mcgarity | Buy | 140,000 | $0.18 |
| Jul 16, 2026 | Jeff Leblanc | Buy | 1,400,000 | $0.18 |
| Jun 25, 2026 | Riad Hussein El-Dada | Sale | 175,000 | $0.23 |
GRML financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-10.55M | -0.22 | $-5.89M |
| Dec 31, 2024 | — | $-6.15M | -0.32 | $-2.95M |
| Dec 31, 2023 | — | $-707.46K | -0.05 | $-446.92K |
| Dec 31, 2022 | — | $1.23M | — | $-493.04K |
Latest balance sheet: total assets $65.01M, total liabilities $7.11M, cash $9.30M (as of Jun 30, 2026).
GRML earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Biogen (BIIB)Halozyme Therapeutics (HALO)Revolution Medicines (RVMD)Recursion Pharmaceuticals (RXRX)ImmunityBio (IBRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on GRML
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.